Clinical trials
Endometrial Neoplasms trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 5 |
| Not yet recruiting | 4 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 5 |
| European Institute of Oncology | 4 |
| Catholic University of the Sacred Heart | 2 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2 |
| ARNAS Civico Di Cristina Benfratelli Hospital | 1 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| Campus Bio-Medico University | 1 |
| Federico II University | 1 |
| Ospedale Regina Montis Regalis | 1 |
| Universita di Verona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 19 |
| Uterine Cervical Neoplasms | 3 |
| Uterine Diseases | 2 |
| Uterine Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Endometrial Hyperplasia | 1 |
| Genital Diseases, Female | 1 |
| Melanoma | 1 |
| Myofibroma | 1 |
| Obesity, Morbid | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.